Literature DB >> 2210085

Diagnostic features and clinical signs of 21 patients with lissencephaly type 1.

J F de Rijk-van Andel1, W F Arts, P G Barth, M C Loonen.   

Abstract

Lissencephaly type I has been described as either the cerebral expression of a complex malformation syndrome such as Miller-Dieker syndrome (MDS), or as isolated lissencephaly sequence (ILS). In a nation-wide study in The Netherlands, of 21 patients with lissecephaly type I, four were found to have MDS and 17 ILS. New clinical aspects were as follows: the mean life-span of the entire group was longer than previously reported; patients with lissencephaly grades 3 or 4 (mixture of agyria and pachygyria, or complete pachygyria) developed seizures later than those with grades 1 and 2 (complete and almost complete agyria); microcephaly was not always present in patients with grades 3 and 4 lissencephaly; and patients with lissencephaly grades 1 and 2 had hardly any psychomotor development, while those with grades 3 and 4 were severely retarded.

Entities:  

Mesh:

Year:  1990        PMID: 2210085     DOI: 10.1111/j.1469-8749.1990.tb08431.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  11 in total

Review 1.  Miller-Dieker syndrome: analysis of a human contiguous gene syndrome in the mouse.

Authors:  Jessica Yingling; Kazuhito Toyo-Oka; Anthony Wynshaw-Boris
Journal:  Am J Hum Genet       Date:  2003-08-05       Impact factor: 11.025

2.  Isolated lissencephaly sequence associated with a microdeletion at chromosome 17p13.

Authors:  J F De Rijk-van Andel; C E Catsman-Berrevoets; D J Halley; E Wesby-van Swaay; M F Niermeijer; B A Oostra
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

3.  Lissencephaly: Expanded imaging and clinical classification.

Authors:  Nataliya Di Donato; Sara Chiari; Ghayda M Mirzaa; Kimberly Aldinger; Elena Parrini; Carissa Olds; A James Barkovich; Renzo Guerrini; William B Dobyns
Journal:  Am J Med Genet A       Date:  2017-04-25       Impact factor: 2.802

4.  Submicroscopic deletions of 17p13.3 in type 1 Lissencephaly.

Authors:  A Mantel; C Leonard; B Husson; N Miladi; M Tardieu; P Landrieu
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

5.  Detecting deletions in the critical region for lissencephaly on 17p13.3 using fluorescent in situ hybridisation and a PCR assay identifying a dinucleotide repeat polymorphism.

Authors:  D T Pilz; A Dalton; A Long; T Jaspan; E L Maltby; O W Quarrell
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

6.  Lissencephaly syndromes: clinical aspects.

Authors:  G Kurlemann; G Schuierer; K Kuchelmeister; M Kleine; J Weglage; D G Palm
Journal:  Childs Nerv Syst       Date:  1993-11       Impact factor: 1.475

7.  Neuropathology of lissencephalies.

Authors:  K Kuchelmeister; M Bergmann; F Gullotta
Journal:  Childs Nerv Syst       Date:  1993-11       Impact factor: 1.475

8.  Clinical manifestations and evaluation of isolated lissencephaly.

Authors:  L Pavone; R Rizzo; W B Dobyns
Journal:  Childs Nerv Syst       Date:  1993-11       Impact factor: 1.475

9.  Neuroimaging in lissencephaly type I.

Authors:  J F de Rijk-van Andel; M S van der Knaap; J Valk; W F Arts
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

10.  Subcortical laminar heterotopia and lissencephaly in two families: a single X linked dominant gene.

Authors:  J M Pinard; J Motte; C Chiron; R Brian; E Andermann; O Dulac
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.